Medline Inc. Class A Common Stock (MDLN) - Total Liabilities
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has total liabilities worth $19.20 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MDLN cash flow conversion to assess how effectively this company generates cash.
Medline Inc. Class A Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how Medline Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. See MDLN book value for net asset value and shareholders' equity analysis.
Medline Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Commerzbank AG
XETRA:CBK
|
Germany | €561.14 Billion |
|
Crown Castle
NYSE:CCI
|
USA | $33.15 Billion |
|
Naspers Limited
F:NNWN
|
Germany | €24.55 Billion |
|
PG&E Corp
NYSE:PCG
|
USA | $108.82 Billion |
|
Keysight Technologies Inc
NYSE:KEYS
|
USA | $5.42 Billion |
|
Interactive Brokers Group Inc
NASDAQ:IBKR
|
USA | $182.77 Billion |
|
CHINA PAC.IN.GR.GDR/5 YC1
F:75CB
|
Germany | €2.81 Trillion |
|
EMCOR Group Inc
NYSE:EME
|
USA | $5.30 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down Medline Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MDLN market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medline Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medline Inc. Class A Common Stock (2023–2025)
The table below shows the annual total liabilities of Medline Inc. Class A Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $19.20 Billion | -1.32% |
| 2024-12-31 | $19.45 Billion | +1.61% |
| 2023-12-31 | $19.14 Billion | -- |
About Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more